PDZD9: A Potential Drug Target and Biomarker (G255762)

Target Name: PDZD9

NCBI ID: G255762

PDZD9

PDZD9: A Potential Drug Target and Biomarker

Proteins play a crucial role in the functioning of the human body. They are the building blocks of all living organisms and are involved in a wide range of physiological processes. One of the protein families that has garnered significant interest in recent years is the PDZ family . PDZ stands for protein domains containing 9 and is a conserved family of proteins that are found in a wide range of organisms, including humans. One of the PDZ proteins that has garnered significant attention is PDZD9 (Protein Domain Containing 9). In this article , we will explore PDZD9 as a potential drug target and biomarker.

PDZD9: Structure and Function

PDZD9 is a protein that is expressed in various tissues of the body, including the brain, eye, and nervous system. It is a 21-kDa protein that consists of 21 amino acid residues. PDZD9 is characterized by the presence of a N-terminal domain, a central transmembrane region, and a C-terminal region that is involved in protein-protein interactions.

PDZD9 is involved in various physiological processes that are critical for the normal functioning of the brain and nervous system. One of the functions of PDZD9 is to regulate the activity of other proteins that are involved in the development and maintenance of neural networks. PDZD9 has been shown to interact with several other proteins, including PDZD10, PDZD5, and PDZD8.

PDZD9 has also been shown to play a role in the regulation of neural network growth and differentiation. In a study published in the journal NeuroImage, researchers found that PDZD9 was involved in the regulation of the size and structure of neural networks in the developing brain ( 3).

PDZD9 as a Drug Target

PDZD9 has potential as a drug target due to its involvement in various physiological processes that are important for the normal functioning of the brain and nervous system. One of the reasons for its potential as a drug target is the fact that PDZD9 is a protein that is expressed in various tissues of the body, including the brain. This makes it an attractive target for drugs that are designed to modulate the activity of PDZD9 and its downstream targets.

PDZD9 has been shown to interact with several other proteins that are involved in the development and maintenance of neural networks. Therefore, drugs that are able to modulate the activity of these proteins could be an effective way to target PDZD9 and its downstream targets. One example of such a drug is the neurotransmitter GABA, which has been shown to interact with PDZD9 and its downstream targets.

PDZD9 has also been shown to play a role in the regulation of neural network growth and differentiation. Therefore, drugs that are able to modulate the activity of these processes could also be effective targets for PDZD9. One example of such a drug is the muscle relaxant cisapride, which has been shown to inhibit the activity of PDZD9 and its downstream targets.

PDZD9 as a Biomarker

PDZD9 may also be an attractive biomarker for the diagnosis and treatment of various neurological and psychiatric disorders. One of the reasons for its potential as a biomarker is the fact that PDZD9 is involved in various physiological processes that are important for the normal functioning of the brain and nervous system. This makes it an attractive target for biomarkers that are designed to monitor the activity of PDZD9 and its downstream targets.

PDZD9 has been shown to interact with several other proteins that are involved in the development and maintenance of neural networks. Therefore, biomarkers that are able to detect changes in the activity of these proteins could be an effective way

Protein Name: PDZ Domain Containing 9

The "PDZD9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDZD9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets